These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37606396)
1. FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator. Shirai R; Cho M; Isogai M; Fukatsu S; Okabe M; Okawa M; Miyamoto Y; Torii T; Yamauchi J Neurol Int; 2023 Aug; 15(3):980-993. PubMed ID: 37606396 [TBL] [Abstract][Full Text] [Related]
2. The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway. Han JH; Ryu HH; Jun MH; Jang DJ; Lee JA Biochem Biophys Res Commun; 2012 May; 421(3):544-9. PubMed ID: 22521643 [TBL] [Abstract][Full Text] [Related]
4. The role of CHMP2B Krasniak CS; Ahmad ST Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529 [TBL] [Abstract][Full Text] [Related]
5. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247 [TBL] [Abstract][Full Text] [Related]
6. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis. Ugbode C; West RJH Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective activity of ursodeoxycholic acid in CHMP2B West RJH; Ugbode C; Fort-Aznar L; Sweeney ST Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425 [TBL] [Abstract][Full Text] [Related]
9. Molecular Genetics of Frontotemporal Dementia Elucidated by Vandal SE; Zheng X; Ahmad ST Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743 [TBL] [Abstract][Full Text] [Related]
10. Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B Waegaert R; Dirrig-Grosch S; Liu H; Boutry M; Luan P; Loeffler JP; René F Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454086 [TBL] [Abstract][Full Text] [Related]
11. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia. Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763 [TBL] [Abstract][Full Text] [Related]
12. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3. Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250 [TBL] [Abstract][Full Text] [Related]
13. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
14. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B. Zhang Y; Schmid B; Nielsen TT; Nielsen JE; Clausen C; Hyttel P; Holst B; Freude KK Stem Cell Res; 2016 Jul; 17(1):151-153. PubMed ID: 27558614 [TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B. Zhang Y; Schmid B; Nielsen TT; Nielsen JE; Clausen C; Hyttel P; Holst B; Freude KK Stem Cell Res; 2016 Jul; 17(1):148-150. PubMed ID: 27558613 [TBL] [Abstract][Full Text] [Related]
16. The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei. Coyne AN; Rothstein JD Acta Neuropathol Commun; 2021 Jul; 9(1):127. PubMed ID: 34281622 [TBL] [Abstract][Full Text] [Related]
17. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review. Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767 [TBL] [Abstract][Full Text] [Related]
18. Expression of mutant CHMP2B linked to neurodegeneration in humans disrupts circadian rhythms in Lee D; Zheng X; Shigemori K; Krasniak C; Bin Liu J; Tang C; Kavaler J; Ahmad ST FASEB Bioadv; 2019 Aug; 1(8):511-520. PubMed ID: 32123847 [TBL] [Abstract][Full Text] [Related]
19. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation. Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491 [TBL] [Abstract][Full Text] [Related]
20. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus. Yamazaki Y; Takahashi T; Hiji M; Kurashige T; Izumi Y; Yamawaki T; Matsumoto M Neurosci Lett; 2010 Jun; 477(2):86-90. PubMed ID: 20420883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]